Calles, Johnrel P.
HRN: 11-28-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
METRONIDAZOLE 500MG (TAB)
09/02/2023
09/08/2023
ORAL
500mg
Q8h
Intestinal Ameobiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes